Paushak Limited has submitted its postal ballot notice to stock exchanges for the special resolution to approve the appointment of Mr. Jain Parkash as Whole-time Director. The company filed the notice on March 17, 2026, with BSE Limited and National Stock Exchange of India Ltd under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Postal Ballot Filing and E-voting Timeline

The company has made necessary arrangements for shareholders to vote exclusively through remote e-voting process, with no physical postal ballot forms being distributed. The postal ballot notice has been uploaded on the company's website at www.paushak.com and will be available on stock exchange websites.

Director Appointment Details

Following the Board meeting held on March 10, 2026, the company seeks shareholder approval for appointing Mr. Jain Parkash (DIN: 10922687) as Whole-time Director and Key Managerial Personnel. This appointment follows the resignation of Mr. Chintan Gosaliya, the outgoing Whole-time Director & COO, effective March 31, 2026.

Professional Background and Remuneration

Mr. Jain Parkash, aged 59 years, brings over 35 years of experience in specialty chemicals, agro-chemicals, and pharmaceutical API/intermediates. He holds a Bachelor of Engineering in Industrial Engineering with Honours from Thapar University, Patiala, along with a Post Graduate Diploma in Human Resources Development and Diploma in Management from IGNOU.

Regulatory Compliance and Voting Process

The company has engaged National Securities Depository Limited (NSDL) as the e-voting service provider. Shareholders whose names appear on the Register of Members as on the cut-off date of March 13, 2026, will be eligible to participate in the e-voting process. The resolution requires approval through special resolution, and if approved, will be deemed passed on April 17, 2026.

The company confirmed that Mr. Jain Parkash is not debarred from holding directorship by SEBI or any regulatory authority and satisfies all conditions under Section 196(3) of the Companies Act, 2013, and Part-I of Schedule V to the Act for his appointment.

Paushak Limited has announced its unaudited financial results for the third quarter of FY26 ended December 31, 2025, showing mixed performance with revenue growth but declining profitability. The Gujarat-based specialty chemicals company's Board of Directors approved the results at a meeting held on January 27, 2026.

Financial Performance Overview

The company's quarterly performance presents a contrasting picture of top-line growth and bottom-line pressure:

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Paushak demonstrated resilience in revenue generation while facing profitability challenges:

Cost Structure and Operational Metrics

The company's expense analysis reveals several key trends affecting profitability. Employee benefits expense increased to ₹1,090 lacs in Q3FY26 from ₹932 lacs in Q3FY25, partly due to additional provisions of ₹101.07 lacs related to new Labour Codes implemented by the Government of India on November 21, 2025. Cost of materials consumed rose to ₹1,198 lacs from ₹976 lacs in the corresponding quarter last year.

Corporate Actions and Structural Changes

Paushak undertook significant corporate restructuring during the period. The company's authorized share capital was reclassified to ₹20 crore divided into 4 crore equity shares of ₹5 each. A major bonus issue was executed with 1,84,92,684 equity shares allotted in a 3:1 ratio on October 6, 2025. The paid-up equity share capital increased substantially to ₹1,233 lacs from ₹308 lacs in the previous year.

Market Expansion and Listing

The company achieved a significant milestone with its equity shares getting listed on the National Stock Exchange of India Limited effective December 1, 2025. This dual listing on both BSE and NSE enhances the company's market accessibility and liquidity for investors. The Board of Directors had approved the NSE listing proposal at their meeting held on October 9, 2025.

Regulatory Compliance and Outlook

The financial results were reviewed by statutory auditors CNK & Associates LLP and approved by the Board of Directors. The company operates exclusively in the specialty chemicals business, maintaining focus on its core competency. The implementation of new Labour Codes represents an ongoing regulatory adaptation that the company is managing through appropriate provisioning mechanisms.